In a CML model, BCR-ABL-expressing Alox5-/- leukemia stem cells (LSCs) display an increased apoptotic rate as compared to wildtype LSCs, indicating the potential importance of the stem cell population for Alox5 and leukemia development [48]. The gene discussed is ALOX5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.